ATRECA INC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ATRECA INC and buy or sell other stocks, options, and ETFs commission-free!

About BCEL

Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. 

CEO
John A. Orwin
CEOJohn A. Orwin
Employees
90
Employees90
Headquarters
San Carlos, California
HeadquartersSan Carlos, California
Founded
2010
Founded2010
Employees
90
Employees90

BCEL Key Statistics

Market cap
3.17M
Market cap3.17M
Price-Earnings ratio
-0.03
Price-Earnings ratio-0.03
Dividend yield
—
Dividend yield—
Average volume
158.27K
Average volume158.27K
High today
$0.0906
High today$0.0906
Low today
$0.08
Low today$0.08
Open price
$0.08
Open price$0.08
Volume
160.68K
Volume160.68K
52 Week high
$1.26
52 Week high$1.26
52 Week low
$0.052
52 Week low$0.052
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.